National Cancer Institute; Cancellation of Meeting

---
identifier: "/us/fr/2023-17186"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Cancellation of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2023-17186"
section_name: "National Cancer Institute; Cancellation of Meeting"
positive_law: false
currency: "2023-08-10"
last_updated: "2023-08-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2023-17186"
document_type: "notice"
publication_date: "2023-08-10"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "88 FR 54331"
fr_volume: 88
---


#  National Cancer Institute; Cancellation of Meeting

Notice is hereby given of the cancellation of the National Cancer Institute Special Emphasis Panel, National Cancer Institute Special Emphasis Panel; SEP-9: NCI Clinical and Translational Cancer Research, October 26, 2023, 12:00 p.m. to October 26, 2023, 4:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W104, Rockville, Maryland 20850 which was published in the *Federal Register* on July 28, 2023, FR Doc 2023-15995, 88 FR 48898.

This meeting is cancelled and will be rescheduled.

Dated: August 7, 2023.

Melanie Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.